Market Overview

UBS Downgrades InterMune To Neutral


Analysts at UBS downgraded InterMune (NASDAQ: ITMN) from Buy to Neutral.

The price target for InterMune has been raised from $52.00 to $74.00.

InterMune shares have jumped 403.30% over the past 52 weeks, while the S&P 500 index has gained 22.33% in the same period.

InterMune shares rose 0.01% to $73.18 at 10:40 a.m. ET.

Latest Ratings for ITMN

Aug 2014Cowen & Co.Initiates Coverage onMarket Perform
Aug 2014UBSDowngradesBuyNeutral
Aug 2014JMP SecuritiesDowngradesMarket OutperformMarket Perform

View More Analyst Ratings for ITMN
View the Latest Analyst Ratings


Related Articles (ITMN)

View Comments and Join the Discussion!

Posted-In: UBSDowngrades Analyst Ratings

Latest Ratings

PTGXJefferiesInitiates Coverage On27.0
GPSRBC CapitalUpgrades18.0
HXLKeyBancInitiates Coverage On55.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at